Alternatively, the BWXT Tc-99m generator will be produced from natural molybdenum targets irradiated at a commercial power reactor, greatly reducing complex waste by-products.

Alternatively, BWXT Medical’s Tc-99m generator will be produced using natural molybdenum targets irradiated at Darlington Nuclear, greatly reducing waste by-products.

Forward-looking statements include, completion of a final collaboration agreement; development of proprietary generator; ;and successfully commercialize production of Tc-99m.These forward-looking ...

Technetium-99m (Tc-99m) radiopharmaceuticals are the major diagnostic tools in the clinical practice of nuclear medicine worldwide covering 35 million procedures annually. They play an important role ...

Alternatively, BWXT Medical’s Tc-99m generator will be produced using natural molybdenum targets irradiated at Darlington Nuclear, greatly reducing waste by-products. In the future, the ...

Both Tc-99m, and the Mo-99 used to produce it inside a Tc-99m generator, are very short-lived so a reliable and steady supply is needed. “We are now working through a controlled start-up process that ...

BWXT has published a presentation on the Investor Relations section of its website about BWXT Medical. The presentation highlights the subsidiary’s Tc-99m generator strategy, its growing nuclear ...

Alternatively, BWXT Medical’s Tc-99m generator will be produced using natural molybdenum targets irradiated at Darlington Nuclear, greatly reducing waste by-products.

“Our Tc-99m generator product is a lower cost, more reliable, drop-in replacement to current generators, and we see it as a key component of our medical portfolio.” ...

This advertisement has not loaded yet, but your article continues below. Tc-99m is used in over 40 million diagnostic procedures annually, and is the daughter isotope of molybdenum-99 (Mo-99).